CAMBRIDGE-Moderna announced Health Canada has approved mRESVIA™ (Respiratory Syncy-al Virus mRNA vaccine) for ac-ve immuniza-on for the preven-on of lower respiratory tract disease caused by respiratory syncy-al virus (RSV) in adults 60 years of age and older.1 “This approval is an example of how our mRNA platform can help address significant public health challenges like RSV,” said Stéphane Bancel, Chief …